作者: Ewout Van Ginneken , Reinhard Busse
DOI: 10.1111/J.1759-8893.2010.00015.X
关键词:
摘要: Objectives To examine expectations of and opinions on the development European Union (EU) national competencies in pharmaceutical policy until 2025. Methods Key issues (authorisation, pharmacovigilance, classification, distribution, advertising, pricing, dispensing, prescribing, post-licensing evaluation reimbursement) were selected from published literature. Next a two-round Delphi questionnaire was developed which 41 experts asked to rate level competence these using five-point Likert scale (1 = fully national, 5 European). findings Experts expect that authorisation, advertising show steady gradual trend towards regulation. Pricing, prescribing reimbursement remain predominantly competencies. Conclusions Convergence due Europeanisation market reinforces opportunities for (and some cases necessitates) more collaboration or National governments are well advised support such collaborations actively participate direction future EU instead resisting it.